TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
CRVO

CervoMed Inc.

Healthcare · Biotechnology

2.40$ -0.8% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement CRVO
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
+36.3% -58.9%
-98.5% +206.5% +168.3% +62.4% -11.3% +5.4% -9.5% +1,330.7% +531.4% +122.8%
+35.4% +61.3% -18.6% +13.0% +15.1% +42.4% -9.8% -14.9% +16.6% +122.8% +16.1%
+19.0% +15.5% +17.3% -25.4% +40.6% +14.4%
-5.6% +132.0% -24.0% +5.7% -3.9% +38.6% +55.5% -35.3% -51.1% +133.3% +55.2%
+14.5% -90.5% +9,729.5% -100.0%
-603.2%
-3,403.3%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?